APO LMV 300 (Lamivudine 300 mg)
Pill imprint APO LMV 300 has been identified as Lamivudine 300 mg.
Lamivudine is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure; hepatitis b and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for APO LMV 300 (Lamivudine 300 mg)
- 300 mg
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Apotex Inc.
Lamivudine is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...